Stock Updates

A look at a High Market Cap Stock: Bristol-Myers Squibb Company, BMY

Bristol-Myers Squibb Company, BMY is in the exchange NYSE and its industry is Drug Manufacturers – Major in the sector of Healthcare. Based in USA, Bristol-Myers Squibb Company, BMY  has a market cap of 125642.32. Since its IPO date on the 6/1/1972, Bristol-Myers Squibb Company, BMY performance year to date is 10.67%. Today Bristol-Myers Squibb Company, BMY has gained 1.62%, with a current price of 75.28.

Ownership of the company is 0.10% for insider ownership while institutional ownership is 74.40%. The management of the company have seen the company have a payout ratio of 159.00%. Return of assets are at 4.90%, with return on investment at 4.60%.

In terms of debt levels and profit levels, Bristol-Myers Squibb Company, BMY is seeing a long-term debt/equity of 0.46. While Total debt/equity is 0.47. With a profit margin of 9.30%, this is combined with a gross margin of 76.00%, and operating margin of 11.60%. Bristol-Myers Squibb Company ability to meet debt levels, with a current ratio of 1.5, while the quick ratio is 1.3.

For the last year Bristol-Myers Squibb Company, BMY has seen a EPS growth of -22.30%. A performance for the year of 13.46%. The 52-week high is 0.74%, and the 52-week low is 48.65%. The average volume for Bristol-Myers Squibb Company, BMY is 5427999.

With a target price of 76.48, can Bristol-Myers Squibb Company, BMY reach this target? Looking at the value indicators of Bristol-Myers Squibb Company, BMY. Bristol-Myers Squibb Company has a P/E of 80.43 and a forward P/E of 23.39. Perhaps the more useful indicator than P/E, is PEG which has a value of 3.52. Bristol-Myers Squibb Company also has a P/S and a P/B of 7.43 and 8.73 respectively. For P/cash, Bristol-Myers Squibb Company has a value of 29.17, while it is *TBA for P/free cash flow.

At the current price of 75.28, Bristol-Myers Squibb Company has a dividend yield of 2.02%. We see a return on equity of 10.70%.

Looking more long-term Bristol-Myers Squibb Company, is projected to get an EPS growth for the next five years of 22.85%. In the short-term an EPS growth of 25.80% in the next year is forecasted. This is after a EPS growth of -22.30% for this year and for the last five years a -12.20% growth has been seen.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Mark Hines

Leave a Comment